| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.10.b
Das S and Chang C (2012)
|
Xla Wt + smurf1 MO
NF10.5 (in situ hybridization)
|
|
|
|
|
fig.10.b
Das S and Chang C (2012)
|
Xla Wt + smurf1 MO + smurf2 MO
NF10.5 (in situ hybridization)
|
|
|
|
|
fig.10.b
Das S and Chang C (2012)
|
Xla Wt + smurf1 MO + smurf2 MO
NF10.5 (in situ hybridization)
|
|
|
|
fig.5.a
Das S and Chang C (2012)
|
Xla Wt + smurf2
NF10.5 (in situ hybridization)
|
|
|
|
|
fig.5.b
Das S and Chang C (2012)
|
Xla Wt + smurf2
NF10.5 (in situ hybridization)
|
|
|
|
|
fig.10.a
Das S and Chang C (2012)
|
Xla Wt + smurf2 MO
NF10.5 (in situ hybridization)
|
|
|
|
|
fig.10.b
Das S and Chang C (2012)
|
Xla Wt + smurf2 MO
NF10.5 (in situ hybridization)
|
|
|
|
fig.3.a
Szenker E et al. (2012)
|
Xla Wt + h3f3a MO
NF10.5-23 (in situ hybridization)
|
|
|
|
fig.S4.a
Szenker E et al. (2012)
|
Xla Wt + h3f3a MO
NF11 (RT-PCR)
|
|
|
|
fig.5.c
Szenker E et al. (2012)
|
Xla Wt + hira MO
NF10.5 (in situ hybridization)
|
|
|